Keyphrases
Quantitative PCR
100%
Peripheral Blood
100%
Colon Adenocarcinoma
100%
Epidermal Growth Factor Receptor
100%
Pancreatic Carcinoma
100%
Lung Carcinoma
100%
Solid Tumors
42%
Renal Cell Carcinoma
42%
Total RNA
28%
Cancer Patients
28%
Healthy Controls
28%
PCR Products
14%
Lung
14%
In(III)
14%
Non-small Cell Lung Cancer (NSCLC)
14%
Epithelial Cells
14%
Southern Blotting
14%
Reverse Transcription
14%
Pancreatic Cancer
14%
Lower Limit
14%
Non-small Cell Lung Cancer Patients
14%
Cancer Cell Lines
14%
PCR Amplification
14%
β2-microglobulin (β2-MG)
14%
Patient-controlled
14%
Agarose Gel
14%
Nested Primers
14%
Colon Cancer Patients
14%
Ethidium Bromide
14%
RT-PCR Assay
14%
Anticoagulated
14%
Cancer 2
14%
Tumor Patients
14%
A431 Cell Line
14%
CDNA Amplification
14%
RNA Integrity
14%
Medicine and Dentistry
Epidermal Growth Factor Receptor
100%
Reverse Transcription Polymerase Chain Reaction
100%
Lung Carcinoma
100%
Colon Carcinoma
100%
Solid Malignant Neoplasm
42%
Kidney Carcinoma
42%
Malignant Neoplasm
14%
Epithelial Cell
14%
Edetic Acid
14%
Southern Blotting
14%
Pancreas Cancer
14%
Non Small Cell Lung Cancer
14%
Cancer Cell Line
14%
Reverse Transcription
14%
Complementary DNA
14%
Non-Small Cell Lung Cancer
14%
Agarose
14%
Beta 2 Microglobulin
14%
Lung
14%
Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor
100%
Pancreas Carcinoma
100%
Colon Carcinoma
100%
Lung Carcinoma
100%
Solid Malignant Neoplasm
42%
Kidney Carcinoma
42%
Malignant Neoplasm
28%
Ethylenediaminetetraacetic Acid
14%
Non Small Cell Lung Cancer
14%
Pancreas Cancer
14%
Complementary DNA
14%
Agarose
14%
Ethidium Bromide
14%
Beta 2 Microglobulin
14%
Immunology and Microbiology
Reverse Transcription Polymerase Chain Reaction
100%
Colon
100%
Epidermal Growth Factor
100%
Cell Line
14%
Ethylenediaminetetraacetic Acid
14%
Southern Blotting
14%
Reverse Transcription
14%
Cancer Cell Line
14%
Beta2-Microglobulin
14%